Is Neupogen a chemotherapy drug?
Patients with Cancer Receiving Strong Chemotherapy NEUPOGEN ® is a prescription medicine used to help the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid) who receive anti-cancer medicines (chemotherapy) that can cause fever and a low blood cell count.
What kind of medicine is filgrastim?
Filgrastim injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a substance that is naturally produced in your body called a colony stimulating factor. Filgrastim helps the bone marrow to make new white blood cells.
Is Neupogen a biologic?
A biosimilar is a biologic medical product that is almost an identical copy of an original medication that is manufactured by a different pharmaceutical company. Chemocare.com uses generic names in all descriptions of drugs. Neupogen, Granix and Zarxio are trade names for filgrastim.
Is Neupogen G-CSF?
NEUPOGEN (filgrastim) was the first FDA-approved granulocyte colony-stimulating factor. Amgen has been a pioneer in developing and delivering G-CSF therapy and launched NEUPOGEN in 1991.
Is filgrastim a chemo drug?
This medication is used to prevent infection and neutropenic (low white blood cells) fevers caused by chemotherapy. Filgrastim is a support medication. It does not treat cancer.
Is filgrastim a biologic?
Tbo-filgrastim (Granix), a stand-alone alternative biologic with a single indication, was also evaluated. All filgrastim administrations of any dose between January 1, 2014, and December 31, 2016, in Medicare Part B claims were identified using Healthcare Common Procedure Coding System billing codes.
Is Neupogen a protein?
Filgrastim (Neupogen) is a man-made protein that is similar to the naturally occurring protein, granulocyte-colony stimulating factor (G-CSF). G-CSF is produced in the body by the immune system and stimulates the formation of one type of white blood cell, the neutrophil.
Is Neupogen a biosimilar?
Granix (tbo-filgrastim), Neupogen (filgrastim) and Neupogen biosimilars are granulocyte colony-stimulating factors (G-CSF) that act on hematopoietic cells by binding to specific cell surface receptors, thereby stimulating proliferation, differentiation, commitment, and end cell functional activation.
Is filgrastim a G-CSF?
About: Filgrastim (Neupogen®, G-CSF) Filgrastim is a man-made version of G-CSF that stimulates white blood cell production, and in particular, neutrophil production. A neutrophil is a type of white blood cell that is responsible for fighting infection and is often decreased during cancer therapy.
What is Neupogen used for?
Neupogen® (filgrastim) is a drug that has been used successfully for cancer patients to stimulate the growth of the white blood cells, making patients less vulnerable to infections, it is expected to help patients who have bone marrow damage from very high doses of radiation in much the same way.
How does Neupogen work?
Neupogen works by stimulating the bone marrow to increase the production of white blood cells. After chemotherapy administration, the medication is given as a subcutaneous injection (in the tissue under the skin).
What’s the difference between Neupogen and Epogen?
The bottom line here is that Procrit (epogen) is used to treat anemia decreased red blood cells. Neupogen (granulocyte colony-stimulating factor), on the other hand, is used to stimulate the production of white blood cells (neutrophils).
Is there an alternative to Neupogen?
With its FDA approval, Zarxio is the first biosimilar to provide an alternative to Neupogen that is similar in safety and efficacy.
What is Neupogen made from?
NEUPOGEN® is a 175 amino acid protein manufactured by recombinant DNA technology. 1 NEUPOGEN® is produced by Escherichia coli (E coli) bacteria into which has been inserted the human granulocyte colony-stimulating factor gene. NEUPOGEN® has a molecular weight of 18‚800 daltons.
What is Neupogen made of?
What is filgrastim biosimilar?
Filgrastim-sndz is the first biosimilar drug approved by the FDA for use in the United States. A series of studies, including a large clinical trial, demonstrated that the efficacy and safety of filgrastim-sndz is comparable to the reference drug, filgrastim, in preventing neutropenia in patients with cancer.
What type of medication is G-CSF?
A drug used under the brand names Neupogen, Zarxio, and Nivestym to treat neutropenia (a lower-than-normal number of white blood cells), prevent infection, and prepare the blood for the collection of certain types of blood cells, and under the brand name Granix to treat neutropenia.